[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cyanotic-heart-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cyanotic-heart-disease":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100652276","localized-evidence-of-cytokine-adsorption-therapy-during-pediatric-cardiac-surgery-a-single-center-randomized-controlled-trial-leat-100652276",false,"NCT07771491","Localized Evidence of Cytokine Adsorption Therapy During Pediatric Cardiac Surgery: A Single Center Randomized Controlled Trial (LEAT)","LEAT","Inclusion Criteria:\n\n* Children (\\\u003C18 years old at study inclusion)\n* Undergoing a cardiac surgery with CPB of expected duration \\> 180min\n* Prophylactic application of HA during CPB for suspected SIRS.\n\nExclusion Criteria:\n\n* Non-ability to gather informed consent from parents or legal representative. Enrolled in conflicting research study\n* Off-pump procedure\n* Non-steroidal anti-inflammatory treatment in the previous 7 days Pregnancy","ALL","0 Years","17 Years",{"count":20,"type":21},120,"ESTIMATED","INTERVENTIONAL",[24],"NA","The Localized Evidence of Cytokine Adsorption Therapy (LEAT) study is a prospective, randomized controlled trial conducted at the Institut Jantung Negara in Malaysia. It evaluates the efficacy and safety of using Jafron HA-60 and HA380 hemoadsorption cartridges to reduce systemic inflammation in pediatric patients undergoing major heart surgery.\n\nObjective This study aims to compare the post-operative inflammatory response in children undergoing cardiac procedures treated with or without a cytokine.\n\nStudy Population All children \\\u003C 18 years of age at the time of enrollment who are scheduled to undergo cardiac surgery involving cardiopulmonary bypass (CPB) with an expected duration of \\>180 minutes.\n\nMethodology This single-center study will randomly assign patients before surgery into 2 groups: 1 group will receive hemoadsorption treatment plus with standard-of-care (intervention group), while the other group will receive standard-of-care (control group) only.\n\nPrimary Endpoint:\n\nTo evaluate changes in IL-6 plasma concentrations over the first 24 hours following the procedure. Analysis will be performed using a linear mixed-effects model (LMM) to capture both between-subject and within-subject variability across repeated time points. This method allows assessment of the overall trajectory of IL-6 and provides a clearer understanding of its temporal pattern throughout the 24-hour post-procedure period.\n\nSecondary Endpoints:\n\n1. Changes cytokines (IL-8, IL-10, IL-1β, and TNF-α) plasma levels over 24 hours\n2. PELOD-2 score on ICU admission, at 48 hours post ICU admission\n3. ICU and hospital length of stay\n4. ICU, hospital, and 28 days mortality\n5. Mechanical - ventilation (MV) free days at day\n6. Renal replacement therapy (RRT) free days at day 28\n7. Vasopressors free days at day 28\n8. Acute kidney injury\n9. Bleeding complications\n10. Post operative liver injury\n\nData Collection:\n\nBlood samples will be taken at five timepoints: before surgery, at ICU admission, and at 6, 24, and 48 hours post-procedure .\n\nDuration: The study is expected to last 24 months.",[27,28,29,30,31],"Congenital Heart Disease","Open Heart Surgery","Cardiopulmonary Bypass","Endocarditis Acute and Subacute","Cyanotic Heart Disease","NOT_YET_RECRUITING","2026-08-13",{"date":35,"type":36},"2026-08-18","ACTUAL",{"date":38,"type":21},"2026-10-01",{"date":40,"type":21},"2028-10-31",{"name":42,"class":43},"Norfaniza Zabidi","OTHER",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":57,"conditions":58,"keywords":59,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":71},"100510499","phase-4-effect-of-methylprednisolone-on-systemic-inflammatory-response-during-pediatric-congenital-open-heart-surgery-100510499","NCT05927233","Effect of Methylprednisolone on Systemic Inflammatory Response During Pediatric Congenital Open-Heart Surgery","Effect of Methylprednisolone on Systemic Inflammatory Response and Clinical Parameters During Pediatric Congenital Open-Heart Surgery: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Children 1 month- 18 years of age\n* Undergoing Cardiac surgery for the first time and requiring CPB\n* Surgeries for both cyatonic and acyanotic heart disease\n\nExclusion Criteria:\n\n* Pre-mature babies (\\\u003C 28 weeks at birth)\n* Neonates\n* Prior cardiac requiring CPB\n* Surgeries requiring CPB \\> 6 hours\n* Surgeries requiring second run of CPB\n* Patients requiring additional steroids during first 24 hours of CICU stay\n* Patient expires within the initial 24 hours CICU stay.\n* Compromised immune system - that is, known immunodeficiency or use of\n* immunomodulatory therapy.\n* Peri-operative presence of two or more clinical or laboratory signs of active infection that were not attributable to any other cause: fever more than 100°F, heart rate or respiratory rate more than the normal range for age, white blood cell count more than 15% of the upper limit of normal, and an elevated C-reactive protein level above baseline.\n* Preoperative mechanical ventilation, and preoperative need of inotropic agents or mechanical circulatory support.\n* Patient already receiving steroids","1 Month","18 Years",{"count":54,"type":21},60,[56],"PHASE4","The goal of this study is to evaluate the effects of steroids on the early postoperative inflammatory response in patients undergoing elective pediatric congenital cardiac surgery, requiring cardiopulmonary bypass (CPB).",[31,29],[60],"Paediatric population","RECRUITING","2024-07-30",{"date":64,"type":36},"2024-07-31",{"date":66,"type":36},"2023-04-01",{"date":68,"type":21},"2025-06-30",{"name":70,"class":43},"Aga Khan University",1]